Predicting acute and late toxicity in prostate cancer stereotactic ablative radiotherapy: the role of dosimetric parameters and prostate volume
Our study highlighted the critical role of moderate-dose regions for acute and late GI and GU toxicity. Prostate treatment plans should be rigorously evaluated, and moderate doses should be minimized. The HU protocol is an eligible choice for five-fraction SABR plans.
Authors
- Melek Tuğçe Yılmaz (ORCID: https://orcid.org/0000-0001-9813-9286)
- Burak Tilki (ORCID: https://orcid.org/0000-0003-2017-7367)
- Pervin Hürmüz (ORCID: https://orcid.org/0000-0003-1221-9192)
- Gökhan Özyiğit (ORCID: https://orcid.org/0000-0002-7497-4348)
- Pantea Bayatfard
- Yağız Yedekci
Institutions
- Hacettepe University (TR)
Publication Details
- Journal
- Strahlentherapie und Onkologie
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1007/s00066-024-02343-2
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Hacettepe Üniversitesi